Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aclarion (ACON) Research & Development (2021 - 2025)

Aclarion (ACON) has disclosed Research & Development for 5 consecutive years, with $302037.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development rose 54.26% year-over-year to $302037.0, compared with a TTM value of $1.0 million through Sep 2025, up 19.22%, and an annual FY2024 reading of $888766.0, up 1.77% over the prior year.
  • Research & Development was $302037.0 for Q3 2025 at Aclarion, up from $270432.0 in the prior quarter.
  • Across five years, Research & Development topped out at $353226.0 in Q2 2022 and bottomed at $162714.0 in Q2 2021.
  • Average Research & Development over 5 years is $230979.2, with a median of $218997.0 recorded in 2022.
  • The sharpest move saw Research & Development soared 117.08% in 2022, then plummeted 31.86% in 2023.
  • Year by year, Research & Development stood at $182101.0 in 2021, then rose by 20.26% to $218997.0 in 2022, then grew by 0.77% to $220679.0 in 2023, then grew by 14.11% to $251826.0 in 2024, then grew by 19.94% to $302037.0 in 2025.
  • Business Quant data shows Research & Development for ACON at $302037.0 in Q3 2025, $270432.0 in Q2 2025, and $198190.0 in Q1 2025.